TGF beta 2

TGFB2
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	1TFG, 2TGI, 4KXZ
Identifiers
Aliases	TGFB2, LDS4, TGF-beta2, transforming growth factor beta 2, G-TSF
External IDs	OMIM: 190220 MGI: 98726 HomoloGene: 2432 GeneCards: TGFB2
Gene location (Human)
Chr.	Chromosome 1 (human)[1]
End	218,444,619 bp[1]
Gene location (Mouse)
Chr.	Chromosome 1 (mouse)[2]
End	186,705,989 bp[2]
RNA expression pattern
	; ; ; ;
	More reference expression data
Gene ontology
Molecular function	• type II transforming growth factor beta receptor binding; • receptor binding; • type III transforming growth factor beta receptor binding; • cytokine activity; • transforming growth factor beta receptor binding; • growth factor activity; • protein homodimerization activity; • amyloid-beta binding; • GO:0001948 protein binding; • protein heterodimerization activity;
Cellular component	• extracellular region; • extracellular matrix; • platelet alpha granule lumen; • extracellular; • axon; • neuronal cell body; • collagen-containing extracellular matrix;
Biological process	• eye development; • regulation of transforming growth factor beta2 production; • response to progesterone; • cell death; • cardioblast differentiation; • positive regulation of integrin biosynthetic process; • protein phosphorylation; • positive regulation of heart contraction; • positive regulation of neuron apoptotic process; • angiogenesis; • negative regulation of epithelial cell proliferation; • uterine wall breakdown; • negative regulation of alkaline phosphatase activity; • negative regulation of macrophage cytokine production; • positive regulation of cell adhesion mediated by integrin; • cellular proliferation; • transforming growth factor beta receptor signaling pathway; • negative regulation of cell proliferation; • positive regulation of stress-activated MAPK cascade; • cell-cell junction organization; • extrinsic apoptotic signaling pathway; • collagen fibril organization; • positive regulation of epithelial cell migration; • neutrophil chemotaxis; • positive regulation of cell growth; • response to wounding; • negative regulation of cell growth; • positive regulation of cardioblast differentiation; • glial cell migration; • wound healing; • positive regulation of ossification; • cardiac muscle cell proliferation; • positive regulation of epithelial to mesenchymal transition; • odontogenesis; • positive regulation of timing of catagen; • positive regulation of immune response; • regulation of complement-dependent cytotoxicity; • positive regulation of protein secretion; • epithelial to mesenchymal transition; • embryonic digestive tract development; • response to hypoxia; • cell-cell signaling; • positive regulation of pathway-restricted SMAD protein phosphorylation; • heart morphogenesis; • platelet degranulation; • salivary gland morphogenesis; • generation of neurons; • negative regulation of immune response; • cell cycle arrest; • cell morphogenesis; • positive regulation of cell proliferation; • positive regulation of phosphatidylinositol 3-kinase signaling; • cell migration; • activation of protein kinase activity; • positive regulation of cell division; • response to drug; • cardiac epithelial to mesenchymal transition; • BMP signaling pathway; • cell development; • skeletal system development; • kidney development; • neural tube closure; • hair follicle development; • outflow tract septum morphogenesis; • membranous septum morphogenesis; • heart valve morphogenesis; • atrioventricular valve morphogenesis; • pulmonary valve morphogenesis; • endocardial cushion morphogenesis; • cardiac right ventricle morphogenesis; • ventricular trabecula myocardium morphogenesis; • endocardial cushion fusion; • atrial septum primum morphogenesis; • neural retina development; • heart development; • male gonad development; • haematopoiesis; • embryonic limb morphogenesis; • hair follicle morphogenesis; • ascending aorta morphogenesis; • dopamine biosynthetic process; • positive regulation of cell cycle; • negative regulation of Ras protein signal transduction; • somatic stem cell division; • neuron development; • inner ear development; • uterus development; • pathway-restricted SMAD protein phosphorylation; • ventricular septum morphogenesis; • atrial septum morphogenesis; • pharyngeal arch artery morphogenesis; • regulation of apoptotic process involved in outflow tract morphogenesis; • substantia propria of cornea development; • cranial skeletal system development; • negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; • positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation; • regulation of receptor activity; • negative regulation of gene expression; • negative regulation of angiogenesis; • positive regulation of Notch signaling pathway; • SMAD protein signal transduction; • positive regulation of pri-miRNA transcription from RNA polymerase II promoter; • embryo development ending in birth or egg hatching; • regulation of timing of catagen; • secondary palate development; • regulation of cell proliferation; • regulation of apoptotic process; • regulation of MAPK cascade;
	Sources:Amigo / QuickGO
Orthologs
	7042
	21808
	ENSG00000092969
	ENSMUSG00000039239
	P61812
	P27090
	NM_003238; NM_001135599
	NM_009367; NM_001329107
	NP_001129071; NP_003229
	NP_001316036; NP_033393
	Wikidata
View/Edit Human	View/Edit Mouse

Transforming growth factor-beta 2 (TGF-β2) is a secreted protein known as a cytokine that performs many cellular functions and has a vital role during embryonic development (alternative names: Glioblastoma-derived T-cell suppressor factor, G-TSF, BSC-1 cell growth inhibitor, Polyergin, Cetermin). It is an extracellular glycosylated protein. It is known to suppress the effects of interleukin dependent T-cell tumors. There are two named isoforms of this protein, created by alternative splicing of the same gene.

Clark DA, Coker R (1998). "Transforming growth factor-beta (TGF-beta)". Int. J. Biochem. Cell Biol. 30 (3): 293–8. doi:10.1016/S1357-2725(97)00128-3. PMID 9611771.
Wick W, Platten M, Weller M (2002). "Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta". J. Neurooncol. 53 (2): 177–85. doi:10.1023/A:1012209518843. PMID 11716069.
Bissell DM (2002). "Chronic liver injury, TGF-beta, and cancer". Experimental & Molecular Medicine. 33 (4): 179–90. doi:10.1038/emm.2001.31. PMID 11795478.
Kalluri R, Neilson EG (2004). "Epithelial-mesenchymal transition and its implications for fibrosis". J. Clin. Invest. 112 (12): 1776–84. doi:10.1172/JCI20530. PMC 297008. PMID 14679171.
Daopin S, Piez KA, Ogawa Y, Davies DR (1992). "Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily" (PDF). Science. 257 (5068): 369–73. doi:10.1126/science.1631557. PMID 1631557.
Schlunegger MP, Grütter MG (1992). "An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2". Nature. 358 (6385): 430–4. doi:10.1038/358430a0. PMID 1641027.
Noma T, Glick AB, Geiser AG, et al. (1992). "Molecular cloning and structure of the human transforming growth factor-beta 2 gene promoter". Growth Factors. 4 (4): 247–55. doi:10.3109/08977199109043910. PMID 1764261.
Bodmer S, Podlisny MB, Selkoe DJ, et al. (1990). "Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease". Biochem. Biophys. Res. Commun. 171 (2): 890–7. doi:10.1016/0006-291X(90)91229-L. PMID 2119582.
Webb NR, Madisen L, Rose TM, Purchio AF (1989). "Structural and sequence analysis of TGF-beta 2 cDNA clones predicts two different precursor proteins produced by alternative mRNA splicing". DNA. 7 (7): 493–7. doi:10.1089/dna.1.1988.7.493. PMID 2850146.
Madisen L, Webb NR, Rose TM, et al. (1988). "Transforming growth factor-beta 2: cDNA cloning and sequence analysis". DNA. 7 (1): 1–8. doi:10.1089/dna.1988.7.1. PMID 3162414.
Barton DE, Foellmer BE, Du J, et al. (1989). "Chromosomal mapping of genes for transforming growth factors beta 2 and beta 3 in man and mouse: dispersion of TGF-beta gene family". Oncogene Res. 3 (4): 323–31. PMID 3226728.
de Martin R, Haendler B, Hofer-Warbinek R, et al. (1988). "Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family". EMBO J. 6 (12): 3673–7. PMC 553836. PMID 3322813.
Marquardt H, Lioubin MN, Ikeda T (1987). "Complete amino acid sequence of human transforming growth factor type beta 2". J. Biol. Chem. 262 (25): 12127–31. PMID 3476488.
Philip A, Bostedt L, Stigbrand T, O'Connor-McCourt MD (1994). "Binding of transforming growth factor-beta (TGF-beta) to pregnancy zone protein (PZP). Comparison to the TGF-beta-alpha 2-macroglobulin interaction". Eur. J. Biochem. 221 (2): 687–93. doi:10.1111/j.1432-1033.1994.tb18781.x. PMID 7513640.
Lin HY, Moustakas A, Knaus P, et al. (1995). "The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands". J. Biol. Chem. 270 (6): 2747–54. doi:10.1074/jbc.270.6.2747. PMID 7852346.
Hildebrand A, Romarís M, Rasmussen LM, et al. (1994). "Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta". Biochem. J. 302. ( Pt 2): 527–34. doi:10.1042/bj3020527. PMC 1137259. PMID 8093006.
López-Casillas F, Payne HM, Andres JL, Massagué J (1994). "Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites". J. Cell Biol. 124 (4): 557–68. doi:10.1083/jcb.124.4.557. PMC 2119924. PMID 8106553.
Fromigué O, Marie PJ, Lomri A (1998). "Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation". J. Cell. Biochem. 68 (4): 411–26. doi:10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T. PMID 9493905.
Mori T, Kawara S, Shinozaki M, et al. (1999). "Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model". J. Cell. Physiol. 181 (1): 153–9. doi:10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K. PMID 10457363.

GRCh38: Ensembl release 89: ENSG00000092969 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000039239 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

gollark: Two access points or a cable is probably going to be better than one really powerful one.

gollark: Alpine Linux is a neat lightweight distro.

gollark: I generally work with languages high-level enough that poking at RAM would be unhelpful, and projects simple enough that I can just `print` a lot.

gollark: You *can* learn programming just with free resources and open-source stuff, but this does seem useful for actually hosting your projects.

gollark: I mean, "worth" is probably wrong if they just give it to people for free, but the cloud hosting credits do seem nice.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000092969 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000039239 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

TGF beta 2

Further reading